Anhui Huaheng Biotechnology to Raise Capital of Two Subsidiaries to Boost Production

MT NewswiresNov 11 01:47 ET

Anhui Huaheng Biotechnology's (SHSE:688639) Anemic Earnings Might Be Worse Than You Think

Simply Wall StNov 4 18:07 ET

Huaheng Biology: Report of Anhui Huaheng Biotechnology Co., Ltd. for the third quarter of 2024

SZSIOct 28 12:00 ET · Announcements

Anhui Huaheng Biotechnology Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 28 12:00 ET · Announcements

Huaheng Biology (688639.SH): The net income for the first three quarters was 0.17 billion yuan, a year-on-year decrease of 46.9%.

Gelonghui October 28th | Hua Heng Biology (688639.SH) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 1.539 billion yuan, a year-on-year increase of 12.82%; the net income attributable to the listed company shareholders was 0.17 billion yuan, a year-on-year decrease of 46.9%; and the basic earnings per share was 0.74 yuan.

Gelonghui FinanceOct 28 04:37 ET

Even With A 35% Surge, Cautious Investors Are Not Rewarding Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Performance Completely

Simply Wall StOct 21 18:23 ET